To: J-R who wrote (10515 ) 8/10/2002 2:45:14 AM From: axial Respond to Hi, J-R,"As I said above - unreal potential with WF10. That is what scares me though - with that unreal potential, shouldn't DMX be reflecting some of that potential in its shareprice??? It isn't, and that puts up a caution flag for me... the old "sounds to good to be true" story..." "Therein may be the crux. When I first heard of WF-10 and Dimethaid (so many years ago it's difficult to remember) it was in the same forum of other "mind boggling" opportunities that were later proved to be, literally, dust." "But what gives one a cautionary pause is that none of the big pharmas have jumped to the bait. Presumably the strategists at companies like Merck, Pfizer, or Novartis have looked at and analyzed all the information on WF-10. If that is the case, why aren't they banging on DMX's door (or previously on Oxo's door)? ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ "That being said, don't put a whole lot of faith in the # of clickthru's on Stockhouse. They are actually multiplied by 9x... Every amount of clickthru's is divisible wholly by nine... Just thought I'd point that out as someone pointed it out to me..." with different IP addresses to click on the post. At the 9th "click", the post will show no viewers. At the 10th. "click" - the post will show 9 viewers. At the 11th - it will still show 9 - all the way to the 19th "click", when it will show 18 viewers.because they originate from the same IP address , will not increment the view counter. Your "click" will only register once.
